Home
Name
MVT
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for MVT
Name
Alternate Names
CL 232315
Mitoxantrone Hydrochloride
Mitozantrone
Novantrone
Abbreviations
DAD
DHAD
DHAQ
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
301739
Primary Site
Histology
None
Remarks
Antibiotic-class antineoplastic. FDA approved uses in adult acute non-lymphocytic leukemia, and prostate cancer pain reduction in combination with prednisone. Novantrone is a synthetic antineoplastic anthracenedione
Coding
This drug should be coded
Name
Alternate Names
Dom-Etoposide
Epipodophyllotoxin derivative
Epipodophyllotoxin ethylidene gluco-pyranoside
Eposine
Ethylidene-Lignan P
Etopophos
Podophyllotoxin derivative
Vepesid
VP 16-213
VP-16
VP-16213
Toposar
Abbreviations
EPEG
VP-16
VP-16-213
Category
Chemotherapy
Subcategory
Epipodophyllotoxin, topoisomerase II inhibitor
Plant alkaloid
NSC Number
141540
Primary Site
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
Oncotepa
Oncotiotepa
Tepa
Tespa
Tespa-min
Tespamine
Thio
Thio-tepa
Thiofozil
Thiophosphamide
Thioplex
Thiotef
Tifosyl
Tio-TEF
Tiofosfamid
Tiofosyl (Sweden)
Tiofozil
Triethylene thiophosphoramide
WR-45312
Abbreviations
STEPA
TESP
TESPA
Thio-TEPA
TSP
TSPA
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
006396
6396
Primary Site
None
Histology
None
Remarks
Cell cycle nonspecific chemotherapeutic agent. FDA approved uses on intravesicular bladder carcinoma, breast adenocarcinoma, malignant intracavitary effusions, Hodgkin's lymphoma, lymphosarcoma, and ovarian adenocarcinoma. Alkylating agent.
Coding
This drug should be coded
